APA
Kitta T., . (20200506). Editorial Comment to Long-term safety and efficacy of antimuscarinic add-on therapy in patients with overactive bladder who had a suboptimal response to mirabegron monotherapy: A multicenter, randomized study in Japan (MILAI II study). : International journal of urology : official journal of the Japanese Urological Association.
Chicago
Kitta Takeya, . 20200506. Editorial Comment to Long-term safety and efficacy of antimuscarinic add-on therapy in patients with overactive bladder who had a suboptimal response to mirabegron monotherapy: A multicenter, randomized study in Japan (MILAI II study). : International journal of urology : official journal of the Japanese Urological Association.
Harvard
Kitta T., . (20200506). Editorial Comment to Long-term safety and efficacy of antimuscarinic add-on therapy in patients with overactive bladder who had a suboptimal response to mirabegron monotherapy: A multicenter, randomized study in Japan (MILAI II study). : International journal of urology : official journal of the Japanese Urological Association.
MLA
Kitta Takeya, . Editorial Comment to Long-term safety and efficacy of antimuscarinic add-on therapy in patients with overactive bladder who had a suboptimal response to mirabegron monotherapy: A multicenter, randomized study in Japan (MILAI II study). : International journal of urology : official journal of the Japanese Urological Association. 20200506.